NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/21/2026
Back to search
Official data from USPTO
WHERE INNOVATION IGNITES HOPE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
WHERE INNOVATION IGNITES HOPE
ST13
US500000099426403Class
42
Filing
99426403
Registration
8222682
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
10
Latest update
04/21/2026
Trademark type
Word
Nice classes
42
Filing date
10/03/2025
Registration date
04/21/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/21/2026
Last transaction
04/21/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
09/03/2025
First use in commerce
09/03/2025
Drawing code
4
Owner type
03
Owner location
Ellicott City, MD, US
Examiner
NUNLEY, CHRISTOPHER MICHAEL
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Natsar Pharmaceuticals, Inc.
Representatives
William A. McComas Jensen & McComas LLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical research; Medical research services; Medical research laboratories; Medical research laboratory services; Providing information about medical research; Providing medical and scientific research information; Pathological testing for medical research purposes; Providing information about medical and scientific research; Medical research in the field of oncology; Medical research in the field of pathology; Medical research in the field of infectious diseases; Medical research services in the field of cancer; Medical research in the field of rare diseases; Providing medical research information in the field of pharmaceuticals; Medical research laboratory services in the field of oncology; Scientific research for medical purposes in the area of cancerous diseases; Medical and scientific research in the field of cancer treatment and diagnosis; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical testing services and information in the field of cancer research and disease classification; Pharmaceutical drug development services
Publications
History of USPTO decisions and trademark events.
10 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/21/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/03/2026
PUBO
PUBLISHED FOR OPPOSITION
03/03/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/25/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/06/2026
DOCK
ASSIGNED TO EXAMINER
02/06/2026
MAFR
APPLICATION FILING RECEIPT MAILED
10/03/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/03/2025
NWAP
NEW APPLICATION ENTERED
10/03/2025
Continuous trademark protection
Get notified about every new filing that threatens WHERE INNOVATION IGNITES HOPE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.